InsidersTradesSigma
Track the 南微医学 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 南微医学 has recorded 16 reports. Market capitalisation: €13.7bn. The latest transaction was reported on 1 December 2023 (Sale). Among the most active insiders: 芮晨为. All data is accessible without an account.
16
Insider Decl.
n/a
Thresholds
€1m
10 ops.
Buy Volume
€10m
6 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,914 of 29,063 companies
64.6
score / 100
Value49
Quality80
FCF yld3.2%
Earn yld4.2%
EV/EBITDA17.0x
ROE13%
Gross mgn64%
Net mgn18%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 December 2023
Declarations16 total
16 of 16 declarations
关于 南微医学
南微医学是一家在 XSHG 市场上市的医疗保健和制药领域的公司。它专注于开发创新的医疗解决方案。